Albert L. Reese's most recent trade in Lexaria Bioscience Corp was a trade of 11,000 Stock Options done . Disclosure was reported to the exchange on May 15, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lexaria Bioscience Corp | Albert L. Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 11,000 | 43,000 | - | - | Stock Options | |
Lexaria Bioscience Corp | Albert L. Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 12,000 | 32,000 | - | - | Stock Options | |
Lexaria Bioscience Corp | Albert L. Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 5,000 | 20,000 | - | - | Stock Options | |
Lexaria Bioscience Corp | Albert L. Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 5,000 | 15,000 | - | - | Stock Options | |
Lexaria Bioscience Corp | Albert L. Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2022 | 3,200 | 10,000 | - | - | Stock Options | |
Lexaria Bioscience Corp | Albert L. Reese | Director | Grant, award, or other acquisition of securities at price $ 1.96 per share. | 24 May 2022 | 5,000 | 10,917 | - | 2.0 | 9,790 | common shares |
Lexaria Bioscience Corp | Albert L. Reese | Director | Grant, award, or other acquisition of securities at price $ 2.01 per share. | 20 May 2022 | 1,799 | 5,917 | - | 2.0 | 3,611 | common shares |
Lexaria Bioscience Corp | Albert L. Reese | Director | Grant, award, or other acquisition of securities at price $ 2.01 per share. | 18 May 2022 | 1,700 | 2,617 | - | 2.0 | 3,414 | common shares |
Lexaria Bioscience Corp | Albert L. Reese | Director | Grant, award, or other acquisition of securities at price $ 2.01 per share. | 18 May 2022 | 1,501 | 4,118 | - | 2.0 | 3,017 | common shares |
Lexaria Bioscience Corp | Albert L. Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 3,400 | 6,800 | - | - | Stock Options | |
Lexaria Bioscience Corp | Albert L. Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 3,400 | 3,400 | - | - | Stock Options |